Genomics Risk Assessment for Cancer and Early Detection (GRACE) program
Risk Pathways
Risk Assessment
Health System
The innovative GRACE program is reshaping breast cancer risk assessment powered by Volpara Risk Pathways.
In this article, learn how AdventHealth recently began piloting a new Genomics Risk Assessment for Cancer and Early Detection (GRACE) program. The first program of its kind in Florida, GRACE combines the use of digital mammography, artificial intelligence (AI) technology and embedded algorithms to assess a patient’s potential risk of developing breast cancer.
